Qingwu Jin

This inventor holds 4 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: Pharmacia & Upjohn Company, Sugen Incorporated, Other. Active years: 2003-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qingwu Jin. Retrieved from https://idiyas.com/inventor/qingwu-jin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 1

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 17(Granted Patents)

Location History:

Palo Alto, CA (US) (2007)
Kalamazoo, MI (US) (2003 - 2009)

Company Filing History:

3 out of 523

Pharmacia & Upjohn Company

1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2009

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7582756 - 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors (2009-09-01),

2. 7247627 - Salts and polymorphs of a pyrrole-substituted indolinone compound (2007-07-24),

3. 7119209 - Process for preparing indolinone derivatives (2006-10-10),

4. 6653308 - 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors (2003-11-25),

Title: Inventor Profile: Qingwu Jin

Introduction

Qingwu Jin is an emerging figure in the field of biopharmaceuticals, based in the United States. Although he holds no patents at this time, his contributions to the industry through his professional experiences are noteworthy.

Latest Patents

As of now, Qingwu Jin does not have any patents registered to his name. This status may change as his career progresses and he continues to work in innovative environments.

Career Highlights

Qingwu Jin has garnered substantial experience working with reputable companies such as F. Hoffmann-La Roche AG and Pharmasset, Inc. These positions have allowed him to develop important skills and insights into drug development and biopharmaceutical research.

Collaborations

Throughout his career, Qingwu Jin has had the opportunity to collaborate with distinguished colleagues, including Steven D. Axt and Keshab Sarma. These associations reflect his engagement with experienced professionals in his field, further enhancing his expertise and potential for future innovations.

Conclusion

While Qingwu Jin may not have patented inventions at this point, his background in significant organizations and collaborations with notable individuals set a strong foundation for future contributions to the biopharmaceutical industry. As he continues to evolve in his career, there may be exciting developments ahead for this talented individual.

Profile summary based on public USPTO records.